Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables

References

• Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. (1995). Asymmetric-membrane tablet coating for osmotic drug delivery. J Control Release, 35:127–36.
   Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, Vyas SP. (2003). Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pump. Int J Pharm, 259:173–9.
   PubMedGoogle Scholar
• Gupta PK, Robinson JR. (1992). Oral controlled release delivery. In: Kydonie A, ed. Treatise on controlled drug delivery. New York: Marcel Dekker, Inc., 255–313.
   Google Scholar
• Verma RK, Krishna DM, Garg S. (2002). Formulation aspect in the development of osmotically controlled oral drug delivery systems. J Control Release, 79:7–27.
   PubMed Web of Science ®Google Scholar
• Okimoto K, Tokunaga Y, Ibuki R, Irie T, Uekama K, Rajewski RA, et al. (2004). Applicabiity of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm, 286:81–8.
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, Shahsavari M, Rajabi-Siahboomi A, Nokhodchi A. (2008). Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm, 68:289–97.
   PubMed Web of Science ®Google Scholar
• Srinkonda S, Kotamrai P, Barclay B. (2006). Osmotic controlled drug delivery systems. In: Li X, Jastin BR, eds. Design of controlled release delivery systems. New York: The McGraw-Hill Companies, Inc., 203–30.
   Google Scholar
• Liu L, Khang G, Rhee JM, Lee HB. (2000). Monolithic osmotic system for nifedipine. J Control Release, 67:309–22.
   PubMed Web of Science ®Google Scholar
• Lu E, Jiang Z, Zhang O, Jiang X. (2003). A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic and expanding agent. J Control Release, 92:375–82.
   PubMed Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. (2004). Controlled porosity osmotic pumps for highly aqueous soluble drug containing hydrophilic polymers as release retardants. Pharm Dev Technol, 9:435–42.
   PubMed Web of Science ®Google Scholar
• Handbook of Pharmaceutical Excipients. (1994). 2nd ed. London: The Pharmaceutical Press.
   Google Scholar
• Edgar KJ, Buchanan CM, Debenham JS, Rundquist PA, Seiler BD, Shelton MC, et al. (2001). Advances in cellulose ester performance and application. Prog Polym Sci, 26:1605–88.
   Web of Science ®Google Scholar
• am Ende MT, Herbig SM, Korsmeyer RW, Chidlaw MB. (2000). Osmotic drug delivery from asymmetric membrane film-coated dosage forms. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Mercel Dekker, Inc., 751–85.
   Google Scholar
• Okimoto K, Miyeki M, Ohnishi N, Rajewski RA, Stella VJ, Irie T, et al. (1998). Design and evaluation of an osmotic pump system for prednisolone, a poorly water soluble drug, using (SBE)7M–β-CD. Pharm Res, 15(10):1562–8.
   PubMed Web of Science ®Google Scholar
• Okimoto K, Ohike A, Ibuki R, Aoki O, Onishi N, Rajewski RA, et al. (1999). Factors affecting membrane-controlled drug release for an osmotic pump tablet utilizing (SBE)7m-CD as both solubilizer and osmotic agent. J Control Release, 60:311–9.
   PubMed Web of Science ®Google Scholar
• Makhija SP, Vavia PR. (2003). Controlled porosity osmotic pump—based controlled release systems of pseudo – ephedrine: 1. Cellulose acetate as a semi-permeable membrane. J Control Release, 89(1):5–18.
   PubMed Web of Science ®Google Scholar
• Lin W, Lee H. (2003). Design for a microporous controlled delivery system for theophylline. J Control Release, 98(8):179–87.
   Google Scholar
• Meier MM, Kanis LA, Soldi V. (2004). Characterization and drug-permeation profiles of microporous and dense cellulose acetate membranes: Influence of plasticizer and pore-forming agent. Int J Pharm, 278(1):99–110.
   PubMed Web of Science ®Google Scholar
• Verma RK, Garg S. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glypizide. Eur J Pharm Biopharm, 57:513–25.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li W, Nie S, Tang X, Peng B, Tian L, et al. (2009). Overcome side identification in PPOP by making orifices on both layers. Int J Pharm, 371(1–2):1–7.
   PubMedGoogle Scholar
• Garg A, Gupta M, Bhargava HM. (2007). Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm, 67:725–31.
   PubMed Web of Science ®Google Scholar
• Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2004). Polymer blends used for the aqueous coating of solid dosage forms: Importance of the type of plasticizer. J Control Release, 99:1–13.
   PubMed Web of Science ®Google Scholar
• Savastano L, Levenberger H, Merkle HP. (1995). Membrane modulated dissolution of oral drug delivery systems. Pharm Acta Helv, 70:117–24.
   PubMedGoogle Scholar
• Narisawa S, Nagata M, Hirakawa Y, Kobayashi M, Yoshino H. (1997). An organic acid-induced sigmoidal release system for oral controlled-release preparations. III: Elucidation of the anomalous drug release behavior through osmotic pumping mechanism. Int J Pharm, 148:85–91.
   Web of Science ®Google Scholar
• Thombre AG, Appel LE, Chidlaw MB, Daugherity FD, Evans LAF, Sutton SC. (2004). Osmotic drug delivery using swellable-core technology. J Control Release, 94(1):75–89.
   PubMed Web of Science ®Google Scholar
• Malaterre V, Pedersen M, Ogorka J, Gurny R, Loggia N, Taday PF. (2009). Terahertz pulse imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems. Eur Pharm Biopharm, in press.
   PubMed Web of Science ®Google Scholar
• Jerzewski RL, Chien YW. (1992). Osmotic drug delivery. In: Kydonieus A, ed. Treatise on controlled drug delivery. New York: Mercel Dekker, Inc., 225–53.
   Google Scholar
• Jantzen GM, Robinson JR. (1996). Sustained- and controlled-release drug delivery systems. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Mercel Dekker, Inc., 575–609.
   Google Scholar
• Venkatraman S, Danar N, Chester A, Kleiner L. (2000). An overview of controlled release systems. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Mercel Dekker, Inc., 431–63.
   Google Scholar
• Ozdemir N, Sahin J. (1997). Design of a controlled release osmotic pump system of Ibuprofen. Int J Pharm, 57:817–20.
   Google Scholar
• Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 68:145–56.
   PubMed Web of Science ®Google Scholar
• Li X, Pan W, Nie S, Wu L. (2004). Study on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe. J Control Release, 96:359–67.
   PubMed Web of Science ®Google Scholar
• Zentner GM, Rork GS, Himmelstein KJ. (1985). The controlled porosity osmotic pump. J Control Release, 4(1):269–82.
   Google Scholar
• Zentner GM, Rork GS, Himmelstein KJ. (1985). Osmotic flow through controlled porosity film: An approach to delivery of water soluble compounds. J Control Release, 2:217–29.
   Google Scholar
• Liu LX, Xu Q, Khang G, Rhee JM, Lee HB. (2003). Unitary-core osmotic pump tablet for the controlled release of water-insoluble drug. Yao Xue Xue Bao, 38(12):966–7.
   PubMedGoogle Scholar
• International Specialty Products. (1999). Plasdone Povidone USP Technical Profile. PLAS/10M/399. New Jersey 07470.
   Google Scholar